Literature DB >> 15172438

Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs.

Fausto Baldanti1, Nell Lurain, Giuseppe Gerna.   

Abstract

The emergence of human cytomegalovirus (HCMV) drug resistant strains is a life-threatening condition in immunocompromised individuals with active HCMV infection. HCMV drug resistance represented a major problem in patients with acquired immunodeficiency syndrome until the recent introduction of highly active antiretroviral combination therapy, which dramatically decreased the incidence in this clinical setting. However, HCMV resistance to antiviral drugs is now an emerging problem in the transplantation setting. The molecular mechanisms of HCMV drug resistance have been elucidated and rely on the selection during treatment of HCMV strains harboring mutations in two key viral genes: UL97 coding for a viral phosphotransferase and UL54 coding for the viral DNA polymerase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172438     DOI: 10.1016/j.humimm.2004.02.007

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  25 in total

1.  Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.

Authors:  Sébastien Hantz; Detlef Michel; Anne-Marie Fillet; Vincent Guigonis; Gaël Champier; Marie-Christine Mazeron; Albert Bensman; François Denis; Thomas Mertens; Axelle Dehee; Sophie Alain
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

3.  Role of defective thymic function in onset of ganciclovir-resistant cytomegalovirus after cord blood transplantation.

Authors:  Sara Cantisán; Carmen Martín; María C Romero-Sánchez; Sara Ferrando-Martínez; Francisco Martínez; Antonio Rivero; Antonio Torres; Rafael Solana; Julián Torre-Cisneros
Journal:  Clin Vaccine Immunol       Date:  2012-10-10

Review 4.  Restoring immune defenses via lymphotoxin signaling: lessons from cytomegalovirus.

Authors:  Theresa A Banks; Sandra Rickert; Carl F Ware
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase.

Authors:  Karl E Zahn; Egor P Tchesnokov; Matthias Götte; Sylvie Doublié
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

6.  Rapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance.

Authors:  Katharina Göhring; Elfriede Mikeler; Gerhard Jahn; Klaus Hamprecht
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

7.  Effective inhibition of HCMV UL49 gene expression and viral replication by oligonucleotide external guide sequences and RNase P.

Authors:  WenJun Zhang; HongJian Li; YueQin Li; ZhiFeng Zeng; ShiQian Li; Xin Zhang; Yi Zou; TianHong Zhou
Journal:  Virol J       Date:  2010-05-18       Impact factor: 4.099

8.  Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samples.

Authors:  Ruth Hall Sedlak; Jared Castor; Susan M Butler-Wu; Elaine Chan; Linda Cook; Ajit P Limaye; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

9.  Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.

Authors:  K Yeon Choi; B Sharon; H H Balfour; K Belani; T C Pozos; M R Schleiss
Journal:  J Clin Virol       Date:  2013-05-18       Impact factor: 3.168

10.  Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.

Authors:  Don B Gammon; Robert Snoeck; Pierre Fiten; Marcela Krecmerová; Antonín Holý; Erik De Clercq; Ghislain Opdenakker; David H Evans; Graciela Andrei
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.